As part of the adaptive reaction to infection from the immune system, inflammation measured by levels of serum inflammatory markers, such as interleukin 6 (IL-6) and C-reactive protein (CRP), can trigger a set of metabolic syndromes and behavioral regulations (Yaffe et al., 2004). This evidence concerns the gene CRP and metabolic syndrome.